Tough Decision Making in Pembrolizumab-Associated Acute Interstitial Nephritis: A Case Report

• Main Authors: João Grilo (Author), Joana Coutinho (Author), Mário Góis (Author), Catarina Reis Santos (Author), Rui Alves Filipe (Author), Ernesto Rocha (Author)
• Format: Book
• Published: Publicações Ciência e Vida, 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pembrolizumab is an immune checkpoint inhibitor used as a cancer therapy. The incidence of immune related adverse events in patients receiving immune checkpoint inhibitors can be as high as 59%-85%. Renal adverse effects are uncommon, but the incidence of kidney toxicity related to pembrolizumab is...